• Skip to content
  • Skip to footer

Oklahoma Medical Research Foundation (OMRF)

Discoveries that make a difference.

  • About
    • Disease Research
    • History
    • Leadership
    • Education & Outreach
    • Effectiveness & Results
    • Events
    • Jobs
    • OMRF at a Glance
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
  • Patients
    • Lupus (SLE)
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Donor Events
    • Tax Credit
    • Gift Planning
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for develop

develop

New findings cast light on lymphatic system, key player in human health

October 16, 2018

OMRF researchers have broken new ground in understanding how the lymphatic system works.

Filed Under: News Tagged With: alzheimers, atherosclerosis, cancer, cell, cell reports, cells, develop, development, disorders, drug targets, drugs, health, infections, Lorin, lymph, lymphatic, lymphedema, news, newsok, obesity, OKC, Oklahoma, Oklahoma City, Oklahoma Medical Research Foundation, Olson, OMRF, pathway, Sathish, Sathish Srinivasan, scientist-news, Srinivasan, st. jude's, system, therapies, therapy

Staying alive: Can an experimental OMRF drug stop Mike Schuster’s brain cancer?

September 11, 2018

As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.

Filed Under: News, Technology Ventures News Tagged With: aggressive, battiste, brain, brain cancer, cancer, deadly, death, develop, disease, drug, glioblastoma, john mccain, life expectancy, live, longer, mike schuster, MRI, newsok, Norman, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OKN-007, OMRF, OUHSC, patients, Rheal, scientist-news, Stephenson Cancer Center, Towner, tumor

OMRF receives $2.8 million grant to study rare disorder

August 23, 2018

The grant will provide Bob Axtell with $2.8 million to study NMO and investigate its similarities to other autoimmune diseases, particularly MS.

Filed Under: News Tagged With: allergy, approved, autoimmune, Axtell, Bob Axtell, brain stem, consequences, develop, disease, infectious diseases, interferon, interferon beta, lupus, multiple sclerosis, National Institutes of Health, neuromyelitis optica, new, news, newsok, NIAID, NIH, NMO, OKC, Oklahoma Medical Research Foundation, OMRF, option, robert, Robert Axtell, scientist-news, therapy, treatment

Experts propose improving clinical trials for lupus

April 23, 2018

The goal of the new white paper is to create a dramatic shift in how lupus clinical trials are conducted so effective treatments can stand a chance to succeed.

Filed Under: News Tagged With: autoimmune disease, barriers, clinical, clinical trials, design, develop, drugs, effort, FDA, illness, immonology, James, Joan, Joan Merrill, Judith, Judith James, lfa, lupus, Lupus Foundation of America, medicine, Merrill, new, Oklahoma Medical Research Foundation, OMRF, projects, research, scientist-news, specialists, therapies, treatment, us, white paper

New colon cancer finding could lead to earlier diagnosis—and better outcomes

March 28, 2018

The most common method of screening for colon cancer is a colonoscopy. However, certain cancer-causing polyps can be easily missed during an examination.

Filed Under: News Tagged With: braf, cancer, CDC, changes, colon cancer, colorectal, Dave Jones, David, David Jones, death, detection, develop, diagnosis, discovery, fecal, Findings, genetic, Jones, killer, lab, leading, mutation, newsok, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, outcomes, plos one, polyps, research, sample, science, scientist-news, test

Q BioMed Inc. finalizes license agreement with OMRF, RGCB

June 15, 2017

QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.

Filed Under: News, Technology Ventures News Tagged With: agreement, cancer, cells, chemo, denis corin, develop, drug, license, liver cancer, medical, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, otcqb, q biomed, qbio, rajiv gandhi centre for biotechnology, research, rgcb, Rheal, rheal towner, rights, scientist-news, therapy, Towner, uttrocide b

  • Page 1
  • Page 2
  • Next Page »

Before Footer

EEO/AA Employer/Vet/Disabled

Top Workplaces logo

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In